Mitomycins [clinicaltrials_resource:a57a2abe33b245a880578c8a08f184c6]
Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer [clinicaltrials:NCT00002507]Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus [clinicaltrials:NCT00002993]Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00003003]clinicaltrials:NCT00003018Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer [clinicaltrials:NCT00003596]Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00003710]clinicaltrials:NCT00003907Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery [clinicaltrials:NCT00004887]Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer [clinicaltrials:NCT00006112]BCG With or Without Mitomycin in Treating Patients With Bladder Cancer [clinicaltrials:NCT00023842]Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer [clinicaltrials:NCT00042887]Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer [clinicaltrials:NCT00068744]A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma [clinicaltrials:NCT00183885]A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer [clinicaltrials:NCT00192049]clinicaltrials:NCT00201747clinicaltrials:NCT00265863clinicaltrials:NCT00271011Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) [clinicaltrials:NCT00289445]The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer [clinicaltrials:NCT00294359]clinicaltrials:NCT00296322clinicaltrials:NCT00296335A Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Patients With Superficial Bladder Cancer [clinicaltrials:NCT00318643]Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C [clinicaltrials:NCT00346489]Customized PRK With Mitomycin Versus Customized Lasik for Myopic Astigmatism [clinicaltrials:NCT00365040]Trabeculectomy With MMC Versus Ahmed Glaucoma Implant for Treatment of Pediatric Aphakic Glaucoma [clinicaltrials:NCT00371072]Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer [clinicaltrials:NCT00384891]Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene [clinicaltrials:NCT00386399]A Comparison of Photorefractive Keratectomy (PRK), PRK With Mitomycin-C and Laser Subepithelial Keratomileusis (LASEK) in the Treatment of Moderate and High Myopia [clinicaltrials:NCT00415077]clinicaltrials:NCT00423293clinicaltrials:NCT00454519Ologen (OculusGen)-Glaucoma MMC Control in Pakistan [clinicaltrials:NCT00472810]Phototherapeutic Keratectomy (PTK) With Mitomycin in Adenoviral Opacities [clinicaltrials:NCT00492245]clinicaltrials:NCT00538590Evaluation of Topical Mitomycin C as Adjuvant Drug to Esophageal Dilation in Children [clinicaltrials:NCT00551824]Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 Seconds [clinicaltrials:NCT00564213]clinicaltrials:NCT00597181Anterior Stromal Changes After PRK by Using Intraoperative Mitomicin C [clinicaltrials:NCT00599950]clinicaltrials:NCT00626782clinicaltrials:NCT00644020Comparison of Subconjunctival 5-Fluorouracil (FU) Injection and Mitomycin C for Treatment of Early Bleb Failure [clinicaltrials:NCT00644215]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Mitomycins [clinicaltrials_resource:a57a2abe33b245a880578c8a08f184c6]
Bio2RDF identifier
a57a2abe33b245a880578c8a08f184c6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a57a2abe33b245a880578c8a08f184c6
identifier
clinicaltrials_resource:a57a2abe33b245a880578c8a08f184c6
title
Mitomycins
@en
type
label
Mitomycins [clinicaltrials_resource:a57a2abe33b245a880578c8a08f184c6]
@en